Developing knowledge resources to support precision medicine: Principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC)

Journal of the American Medical Informatics Association

Volumn 23, Issue 4, 2016, Pages 796-801

  Hoffman, James M ^a   Dunnenberger, Henry M ^b   Hicks, J Kevin ^c   Caudle, Kelly E ^a   Carrillo, Michelle Whirl ^d   Freimuth, Robert R ^e   Williams, Marc S ^f   Klein, Teri E ^d   Peterson, Josh F ^g  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d STANFORD UNIVERSITY   (United States)

^e MAYO CLINIC   (United States)

^f GEISINGER HEALTH SYSTEM   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Clinical decision support systems; Electronic health records; Knowledge bases; Pharmacogenetics; Precision medicine

Indexed keywords

ARTICLE; CLINICAL DECISION SUPPORT SYSTEM; ELECTRONIC HEALTH RECORD; HUMAN; KNOWLEDGE BASE; PERSONALIZED MEDICINE; PHARMACOGENETICS; POINT OF CARE SYSTEM; PRACTICE GUIDELINE; FACTUAL DATABASE;

DATABASES, FACTUAL; DECISION SUPPORT SYSTEMS, CLINICAL; ELECTRONIC HEALTH RECORDS; HUMANS; KNOWLEDGE BASES; PHARMACOGENETICS; PRECISION MEDICINE;

EID: 84981165074     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1093/jamia/ocw027     Document Type: Article

References (48)

1. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med. 2015;372(9):793-795.
2. Jameson JL, Longo DL. Precision medicine: personalized, problematic, and promising. N Engl J Med. 2015;372(23):2229-2234.
3. Dunnenberger HM, Crews KR, Hoffman JM, et al. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Ann Rev Pharmcol Toxicol. 2015;55:89-106.
4. Hicks JK, Crews KR, Hoffman JM, et al. A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin Pharm Ther. 2012;92(5):563-566.
5. Peterson JF, Bowton E, Field JR, et al. Electronic health record design and implementation for pharmacogenomics: a local perspective. Genet Med. 2013;15(10):833-841.
6. Hoffman JM, Haidar CE, Wilkinson MR, et al. PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics. Am J Med Genet C Semin Med Genet. 2014;166C(1):45-55.
7. Shuldiner AR, Relling MV, Peterson JF, et al. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharm Ther. 2013; 94(2):207-210.
8. Bell GC, Crews KR, Wilkinson MR, et al. Development and use of active clinical decision support for preemptive pharmacogenomics. J Am Med Inform Assoc. 2014;21(e1):e93-e99.
9. Van Driest SL, Shi Y, Bowton EA, et al. Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing. Clin Pharm Ther. 2014;95(4):423-431.
10. Pulley JM, Denny JC, Peterson JF, et al. Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. Clin Pharm Ther. 2012;92(1):87-95.
11. Bielinski SJ, Olson JE, Pathak J, et al. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol. Mayo Clin Proc. 2014;89(1): 25-33.
12. Williams MS. Genomic medicine implementation: learning by example. Am J Med Genet C Semin Med Genet. 2014;166C(1):8-14.
13. Payne TH, Corley S, Cullen TA, et al. Report of the AMIA EHR 2020 task force on the status and future direction of EHRs. J Am Med Inform Assoc. 2015;pii:ocv066.
14. Wei WQ, Leibson CL, Ransom JE, et al. Impact of data fragmentation across healthcare centers on the accuracy of a high-throughput clinical phenotyping algorithm for specifying subjects with type 2 diabetes mellitus. J Am Med Inform Assoc. 2012;19(2):219-224.
15. Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308-311.
16. Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980-D985.
17. Online Mendelian Inheritance in Man. http://omim.org/. Accessed August 28, 2015.
18. Coordinators NR. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2015;43:D6-D17.
19. Starren J, Williams MS, Bottinger EP. Crossing the omic chasm: A time for omic ancillary systems. JAMA. 2013;309(12):1237-1238.
20. Caudle KE, Klein TE, Hoffman JM, et al. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab. 2014;15(2):209-217.
21. Martin MA, Hoffman JM, Freimuth RR, et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update. Clin Pharm Ther. 2014;95(5):499-500.
22. Saito Y, Stamp LK, Caudle KE, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharm Ther. 2015, [Epub ahead of print, doi: 10.1002/cpt.161].
23. Caudle KE, Rettie AE, Whirl-Carrillo M, et al. Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing. Clin Pharm Ther. 2014;96(5):542-548.
24. Ramsey LB, Johnson SG, Caudle KE, et al. The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy: 2014 update. Clin Pharm Ther. 2014;96(4):423-428.
25. Hicks JK, Bishop JR, Sangkuhl K, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors. Clin Pharm Ther. 2015;98(2):127-134.
26. Birdwell KA, Decker B, Barbarino JM, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Clin Pharm Ther. 2015;98(1):19-24.
27. Hoffman MA, Williams MS. Electronic medical records and personalized medicine. Hum Genet. 2011;130(1):33-39.
28. Kannry JL, Williams MS. Integration of genomics into the electronic health record: mapping terra incognita. Genet Med. 2013;15(10):757-760.
29. Shoenbill K, Fost N, Tachinardi U, Mendonca EA. Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations. J Am Med Inform Assoc. 2014;21(1):171-180.
30. Chute CG, Kohane IS. Genomic medicine, health information technology, and patient care. JAMA. 2013;309(14):1467-1468.
31. Ramos EM, Din-Lovinescu C, Berg JS, et al. Characterizing genetic variants for clinical action. Am J Med Genet C Semin Med Genet. 2014; 166C(1):93-104.
32. Manolio TA, Chisholm RL, Ozenberger B, et al. Implementing genomic medicine in the clinic: the future is here. Genet Med. 2013;15(4): 258-267.
33. Kullo IJ, Jarvik GP, Manolio TA, Williams MS, Roden DM. Leveraging the electronic health record to implement genomic medicine. Genet Med. 2012;15(4):270-271.
34. Masys DR, Jarvik GP, Abernethy NF, et al. Technical desiderata for the integration of genomic data into Electronic Health Records. J Biomed Inform. 2012;45(3):419-422.
35. Welch BM, Eilbeck K, Del Fiol G, Meyer LJ, Kawamoto K. Technical desiderata for the integration of genomic data with clinical decision support. J Biomed Inform. 2014;51:3-7.
36. Thorn CF, Klein TE, Altman RB. PharmGKB: the pharmacogenomics knowledge base. Methods Mol Bio. 2013;1015:311-320.
37. Whirl-Carrillo M, McDonagh E, Hebert J, et al. Pharmacogenomics knowledge for personalized medicine. Clin Pharm Ther. 2012;92(4):414-417.
38. Clinical Pharmacogenetics Implementation Consortium(CPIC). CPIC Genes/ Drugs Legend. https://cpicpgx.org/genes-drugs/. Accessed January 20, 2016.
39. Kuperman GJ, Reichley RM, Bailey TC. Using commercial knowledge bases for clinical decision support: opportunities, hurdles, and recommendations. J Am Med Inform Assoc. 2006;13(4):369-371.
40. Wilcox AR, Neri PM, Volk LA, et al. A novel clinician interface to improve clinician access to up-to-date genetic results. J Am Med Inform Assoc. 2014;21(e1):e117-e121.
41. Shirts BH, Salama JS, Aronson SJ, et al. CSER and eMERGE: current and potential state of the display of genetic information in the electronic health record. J Am Med Inform Assoc. 2015:pii: ocv065.
42. Goldspiel BR, Flegel WA, DiPatrizio G, et al. Integrating pharmacogenetic information and clinical decision support into the electronic health record. J Am Med Inform Assoc. 2014;21(3):522-528.
43. Rasmussen-Torvik LJ, Stallings SC, Gordon AS, et al. Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin Pharm Ther. 2014;96:482-489.
44. Rehm HL, Berg JS, Brooks LD, et al. ClinGen: The Clinical Genome Resource. N Engl J Med. 2015;372(23):2235-2242
45. ClinGen EHR WG. http://clinicalgenome.org/about/working-groups/ehr/ Accessed August 31, 2015.
46. NHGRI. Genomic Medicine Meeting VII: Genomic Clinical Decision Support: Developing Solutions for Clinical and Research Implementation. https:// www.genome.gov/27558904. Accessed August 28, 2015.
47. National Academy of Medicine. DIGITizE: Displaying and Integrating Genetic Information Through the EHR http://iom.nationalacademies.org/Activities/ Research/GenomicBasedResearch/Innovation-Collaboratives/EHR.aspx. Accessed August 28, 2105.
48. National Academy of Medicine. IOM Use Models Pharmacogenomic Use Pilot for TPMT (Thiopurine) and CYP2C19 (Plavix) http://iom.nationalacademies.org/ ~/media/Files/Activity%20Files/Research/GenomicBasedResearch/Action% 20Collaboratives/Pharmacogenetics%20Standards%20Model.pdf?la�en. Accessed August 28, 2015.